Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythrocyte Carbonic Anhydrase II as a Marker of Metabolic Adaptation to Basketball-Specific High-Intensity Interval Training

NCT07377851 is registered in ClinicalTrials.gov with Karamanoğlu Mehmetbey University as lead sponsor.

NCT NCT07377851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07377851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythrocyte Carbonic Anhydrase II as a Marker of Metabolic Adaptation to Basketball-Specific High-Intensity Interval Training
Lead sponsor
Karamanoğlu Mehmetbey University
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2025
Completion date
January 15, 2026
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic adaptation to high-intensity interval training